BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37345530)

  • 1. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
    Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
    J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
    Vishnu MS; Pavankumar V; Kumar S; Raja AS
    ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of a library of piperonylic acid-derived hydrazones possessing variable aryl functionalities as potent dual cholinesterase and monoamine oxidase inhibitors.
    Kumar VP; Vishnu MS; Kumar S; Jaiswal S; Ayyannan SR
    Mol Divers; 2023 Dec; 27(6):2465-2489. PubMed ID: 36355337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
    Tripathi RK; Rai GK; Ayyannan SR
    ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
    Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
    Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
    Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
    Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
    Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
    Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
    Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.
    D'Ascenzio M; Chimenti P; Gidaro MC; De Monte C; De Vita D; Granese A; Scipione L; Di Santo R; Costa G; Alcaro S; Yáñez M; Carradori S
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):908-19. PubMed ID: 25807300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
    Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP
    Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases.
    Zaib S; Khan I; Ali HS; Younas MT; Ibrar A; Al-Odayni AB; Al-Kahtani AA
    Int J Biol Macromol; 2024 Jun; 272(Pt 1):132748. PubMed ID: 38821306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
    Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group.
    Tripathi RK; Ayyannan SR
    ChemMedChem; 2016 Jul; 11(14):1551-67. PubMed ID: 27332045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
    Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
    Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
    Molecules; 2020 May; 25(10):. PubMed ID: 32443652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.